Stock GLAND GLAND PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Gland Pharma Limited Bombay S.E.

Equities

GLAND

INE068V01023

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 03:30:52 28/06/2024 pm IST 		5-day change 1st Jan Change
1,824 INR +0.37% Intraday chart for Gland Pharma Limited -0.53% -5.15%
20/06 Fosun Pharma Trims Stake in Gland Pharma to 51.83% MT
18/06 Fosun Pharma Industrial Reportedly to Pare 5% Stake in Gland Pharma for $172 Million CI

Business Summary

Gland Pharma Limited is an India-based generic injectables manufacturer. The Company specializes in sterile injectables, oncology, and ophthalmic, with a specific focus on complex injectables, NCE-1s (New Chemical Entities), First-to-File products, and 505(b)(2) filings. The Company functions primarily on a business-to-business (B2B) model and has a record in pharmaceutical research and development, manufacturing, and marketing of complex injectables. The Company offers a range of delivery systems, including liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags, and drops. It is also in the process of including new delivery systems such as pens and cartridges into its product portfolio. Its key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, Daptomycin Injection, among others. Its therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Gynaecological, Hormones, and others.

Number of employees: 4,208

Sales per Business

INR in Million2022Weight2023Weight Delta
Generic Injectibles
100.0 %
44,007 100.0 % 36,246 100.0 % -17.64%

Sales per region

INR in Million2022Weight2023Weight Delta
United States
57.7 %
23,327 53.0 % 20,910 57.7 % -10.36%
Rest of World
19.0 %
8,481 19.3 % 6,893 19.0 % -18.73%
India
15.3 %
8,801 20.0 % 5,548 15.3 % -36.96%
Europe
5.2 %
2,398 5.4 % 1,871 5.2 % -21.97%
Canada
2.2 %
829 1.9 % 795 2.2 % -4.14%
Australia
0.6 %
171 0.4 % 218 0.6 % +27.72%
New Zealand
0.0 %
-- 11 0.0 % -

Managers

Managers TitleAgeSince
Srinivas Sadu CEO
 Chief Executive Officer 55 01/00/01
Ravi Shekhar Mitra DFI
 Director of Finance/CFO - 30/19/30
C. S. Venkatesan CTO
 Chief Tech/Sci/R&D Officer - 01/98/01
Pallerlamudi Sampath Kumar CMP
 Compliance Officer - 01/10/01
Surapanini Sridevi CTO
 Chief Tech/Sci/R&D Officer - 01/02/01
Manish Bharadwaj HRO
 Human Resources Officer - -
Rong Wu AUD
 Comptroller/Controller/Auditor - -
Shilpi Sahay PRN
 Corporate Officer/Principal - 01/14/01
Ashish Adhikari PRN
 Corporate Officer/Principal - 12/19/12

Members of the board

Members of the board TitleAgeSince
Fang Yao BRD
 Director/Board Member 54 10/22/10
Srinivas Sadu CEO
 Chief Executive Officer 55 01/00/01
Qi Yu Chen BRD
 Director/Board Member 52 03/17/03
Udo Johannes Vetter BRD
 Director/Board Member 69 07/18/07
Naina Lal Kidwai BRD
 Director/Board Member 67 17/21/17
Satyanaraynna Murthy Chavali BRD
 Director/Board Member 57 20/18/20
Essaji Goolam Vahanvati BRD
 Director/Board Member - 30/20/30
Jia Ai Zhang BRD
 Director/Board Member - 17/21/17

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 164,751,723 63,239,460 ( 38.38 %) 0 38.38 %

Shareholders

NameEquities%Valuation
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
51.84 %
85,393,894 51.84 % 1 882 M ₹
Mirae Asset Investment Managers (India) Pvt Ltd.
6.471 %
10,658,831 6.471 % 235 M ₹
Nippon Life India Asset Management Ltd. (Invt Mgmt)
5.697 %
9,383,169 5.697 % 207 M ₹
HDFC Asset Management Co. Ltd. (Invt Mgmt)
4.679 %
7,707,234 4.679 % 170 M ₹
SBI Funds Management Ltd.
3.020 %
4,974,107 3.020 % 110 M ₹
UTI Asset Management Co. Ltd. (Investment Management)
1.768 %
2,911,445 1.768 % 64 M ₹
Aditya Birla Sun Life Amc Ltd. (Investment Management)
0.8544 %
1,407,206 0.8544 % 31 M ₹
Invesco Asset Management (India) Pvt Ltd.
0.4213 %
693,963 0.4213 % 15 M ₹
HDFC ASSET MANAGEMENT COMPANY LIMITED
0.4029 %
663,649 0.4029 % 15 M ₹
Bandhan Asset Management Co. Ltd.
0.2459 %
405,000 0.2459 % 9 M ₹

Company contact information

Gland Pharma Ltd.

TSIIC Phase: IV Plot No. 11 & 84

502307, Sangareddy

+91 84 5569 9999

http://www.glandpharma.com
address Gland Pharma Limited(GLAND)

Group companies

NameCategory and Sector
Gland Pharma International Pte Ltd.
Logo Gland Pharma International Pte Ltd.

Gland Pharma International Pte Ltd.

Pharmaceuticals: MajorHealth Technology

Gland Pharma International Pte Ltd. is a Singaporean company that manufactures liquid parenteral products. The private company is based in Singapore, Singapore and was founded in 2021.

Pharmaceuticals: Major

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Ratings for Gland Pharma Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
1,817 INR
Average target price
1,827 INR
Spread / Average Target
+0.55%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+56.37% 82TCr
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.53% 35TCr
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.56% 33TCr
ABBVIE INC. Stock AbbVie Inc.
+9.37% 30TCr
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.91% 24TCr
ROCHE HOLDING AG Stock Roche Holding AG
+2.04% 23TCr
NOVARTIS AG Stock Novartis AG
+13.22% 22TCr
AMGEN INC. Stock Amgen Inc.
+8.96% 17TCr
PFIZER, INC. Stock Pfizer, Inc.
-2.85% 16TCr
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. GLAND Stock
  4. GLAND Stock
  5. Company Gland Pharma Limited